TD Cowen lifts Axon stock target to $800, maintains buy rating

TD Cowen raised its price target on Axon Enterprise (AXON) to $800 from $750, reiterating a Buy rating, after positive commentary from Axon's President at a recent conference. The increased target reflects confidence in Axon's growth, driven by strong Q1 results with a 31% year-over-year revenue increase to $604 million, and multiple growth drivers within its Enterprise and International segments, Draft One & AI technology, and TASER products. Axon is currently trading near its 52-week high, with a valuation of approximately 19 times its expected 2026 enterprise value to sales ratio.

Analysis

Axon Enterprise (NASDAQ:AXON) has received a reiterated Buy rating and an increased price target to $800 from $750 by TD Cowen, following positive insights from Axon's President, Josh Isner, at a recent conference and the company's strong financial performance. Axon reported robust first-quarter 2025 results, with revenue of $604 million, a 31% year-over-year increase and surpassing the anticipated $585.67 million, while earnings per share reached $1.41, beating the forecast of $1.30. This performance marks Axon's 13th consecutive quarter of double-digit revenue growth. The company's strategic growth drivers include its Enterprise and International segments, advancements in Draft One & AI technology, ongoing demand from state and local government budgets, its TASER products, and drone technology. Axon's stock has demonstrated significant strength, with a 26.36% year-to-date increase, trading near its 52-week high of $755.05. The current valuation is approximately 19 times its expected 2026 enterprise value to sales ratio, reflecting strong revenue growth of 32.71% and impressive gross profit margins of 60.6%. Axon maintains a healthy balance sheet with more cash than debt and is targeting over 30% growth at an approximate $2.5 billion run-rate scale. Other analysts, including Raymond James and JMP, also maintain positive outlooks, though InvestingPro data suggests Axon may be trading above its Fair Value and was not highlighted as a top undervalued pick by its AI algorithms.

Key Decisions for Investors

• Investors should acknowledge Axon's sustained strong revenue growth, consistent earnings outperformance, and positive analyst sentiment, driven by a diversified portfolio of growth initiatives including AI, international expansion, and enterprise solutions.
• Careful consideration of the stock's current valuation, trading near its 52-week high at approximately 19 times projected 2026 EV/Sales, is warranted, especially in light of InvestingPro's assessment suggesting it may be above its intrinsic fair value.
• Monitor Axon's ability to execute on its ambitious growth targets of over 30% and its progress in key technological areas like AI and Draft One, as well as developments shared during events like Axon Week, for indications of sustained momentum.